The serum OPN assay performed by Pass et al. presented a sensitivity of 77.6% and a specificity of 85.5%, denoting OPN as a promising biomarker of MM identification in clinical routine [148]. This evidence concerns the gene SPP1 and Miyoshi myopathy.